|
|
|
Insider
Information: |
Van Houte Hans |
Relationship: |
Chief Financial Officer |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
68,333 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
68,333 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nurix Therapeutics, Inc. |
NRIX |
Chief Financial Officer |
2024-05-02 |
68,333 |
2021-02-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2024-05-02 |
4 |
AS |
$12.83 |
$44,878 |
D/D |
(3,499) |
68,333 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2024-04-30 |
4 |
S |
$12.04 |
$16,703 |
D/D |
(1,387) |
71,832 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2024-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,886 |
73,219 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2024-02-16 |
4 |
AS |
$10.02 |
$68,223 |
D/D |
(6,812) |
68,333 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2024-01-30 |
4 |
S |
$7.99 |
$13,352 |
D/D |
(1,671) |
75,145 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,886 |
76,816 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-12-20 |
4 |
AS |
$10.00 |
$35,421 |
D/D |
(3,541) |
71,930 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-12-19 |
4 |
AS |
$10.00 |
$109,093 |
D/D |
(10,906) |
75,471 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-10-31 |
4 |
S |
$5.20 |
$5,613 |
D/D |
(1,080) |
86,377 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,886 |
87,457 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-07-31 |
4 |
S |
$9.65 |
$12,020 |
D/D |
(1,245) |
82,571 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,886 |
83,816 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-05-01 |
4 |
S |
$9.88 |
$7,121 |
D/D |
(721) |
78,930 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,886 |
79,651 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-01-30 |
4 |
S |
$11.78 |
$10,884 |
D/D |
(924) |
76,765 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2023-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,886 |
77,689 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2022-10-31 |
4 |
S |
$12.88 |
$9,519 |
D/D |
(739) |
74,803 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2022-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,886 |
75,542 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2022-08-01 |
4 |
S |
$15.67 |
$11,784 |
D/D |
(752) |
72,656 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2022-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,886 |
73,408 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2022-05-31 |
4 |
OE |
$0.84 |
$57,400 |
D/D |
68,333 |
70,522 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2022-05-02 |
4 |
S |
$11.75 |
$8,190 |
D/D |
(697) |
2,189 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2022-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,886 |
2,886 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2021-02-24 |
4 |
AS |
$39.90 |
$1,413,218 |
D/D |
(35,419) |
0 |
0 |
- |
|
NRIX |
Nurix Therapeutics, Inc. |
Chief Financial Officer |
|
2021-02-24 |
4 |
OE |
$1.20 |
$62,297 |
D/D |
35,419 |
35,419 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|